Deoxyribonuclease is prognostic in patients undergoing transcatheter aortic valve replacement.
Mangold A, Ondracek AS, Hofbauer TM, Artner T, Nechvile J, Panagiotides NG, Mirna M, Hammerer M, Fejzic D, Hoppe U, Wernly B, Lauten A, Alushi B, Franz M, Schulze PC, Wohlschläger-Krenn E, Lang IM, Lichtenauer M.
Mangold A, et al.
Eur J Clin Invest. 2021 Nov;51(11):e13595. doi: 10.1111/eci.13595. Epub 2021 Jun 8.
Eur J Clin Invest. 2021.
PMID: 34101826
Free PMC article.